381 related articles for article (PubMed ID: 26142830)
1. Effect of rovatirelin, a novel thyrotropin-releasing hormone analog, on the central noradrenergic system.
Ijiro T; Nakamura K; Ogata M; Inada H; Kiguchi S; Maruyama K; Nabekura J; Kobayashi M; Ishibashi H
Eur J Pharmacol; 2015 Aug; 761():413-22. PubMed ID: 26142830
[TBL] [Abstract][Full Text] [Related]
2. Excitation of locus coeruleus noradrenergic neurons by thyrotropin-releasing hormone.
Ishibashi H; Nakahata Y; Eto K; Nabekura J
J Physiol; 2009 Dec; 587(Pt 23):5709-22. PubMed ID: 19840999
[TBL] [Abstract][Full Text] [Related]
3. Rovatirelin ameliorates motor dysfunction in the cytosine arabinoside-induced rat model of spinocerebellar degeneration via acetylcholine and dopamine neurotransmission.
Ijiro T; Yaguchi A; Yokoyama A; Kiguchi S
Clin Exp Pharmacol Physiol; 2022 Sep; 49(9):950-958. PubMed ID: 35637550
[TBL] [Abstract][Full Text] [Related]
4. Ameliorating effect of rovatirelin on the ataxia in rolling mouse Nagoya.
Ijiro T; Yaguchi A; Yokoyama A; Abe Y; Kiguchi S
Eur J Pharmacol; 2020 Sep; 882():173271. PubMed ID: 32534077
[TBL] [Abstract][Full Text] [Related]
5. Non-clinical pharmacokinetic profiles of rovatirelin, an orally available thyrotropin-releasing hormone analogue.
Kobayashi K; Abe Y; Harada H; Oota E; Endo T; Takeda H
Xenobiotica; 2019 Jan; 49(1):106-119. PubMed ID: 29300135
[TBL] [Abstract][Full Text] [Related]
6. Lack of behavioral tolerance by repeated treatment with taltirelin hydrate, a thyrotropin-releasing hormone analog, in rats.
Asai H; Asahi T; Yamamura M; Yamauchi-Kohno R; Saito A
Pharmacol Biochem Behav; 2005 Dec; 82(4):646-51. PubMed ID: 16368129
[TBL] [Abstract][Full Text] [Related]
7. Discovery of the Orally Effective Thyrotropin-Releasing Hormone Mimetic: 1-{
Kobayashi N; Sato N; Fujimura Y; Kihara T; Sugita K; Takahashi K; Koike K; Sugawara T; Tada Y; Nakai H; Yoshikawa T
ACS Omega; 2018 Oct; 3(10):13647-13666. PubMed ID: 30411045
[TBL] [Abstract][Full Text] [Related]
8. Chronic citalopram administration desensitizes prefrontal cortex but not somatodendritic α
Fernández-Pastor B; Ortega JE; Grandoso L; Castro E; Ugedo L; Pazos Á; Meana JJ
Neuropharmacology; 2017 Mar; 114():114-122. PubMed ID: 27908769
[TBL] [Abstract][Full Text] [Related]
9. [Synthesis and pharmacological action of TRH analog peptide (Taltirelin)].
Yamamura M; Suzuki M; Matsumoto K
Nihon Yakurigaku Zasshi; 1997 Oct; 110 Suppl 1():33P-38P. PubMed ID: 9503402
[TBL] [Abstract][Full Text] [Related]
10. Diversity of thyrotropin-releasing hormone receptors in the pituitary and discrete brain regions of rats.
Asai H; Kinoshita K; Yamamura M; Matsuoka Y
Jpn J Pharmacol; 1999 Mar; 79(3):313-7. PubMed ID: 10230859
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic Drug Interactions of an Orally Available TRH Analog (Rovatirelin) With a CYP3A4/5 and P-Glycoprotein Inhibitor (Itraconazole).
Kobayashi K; Abe Y; Kawai A; Furihata T; Endo T; Takeda H
J Clin Pharmacol; 2020 Oct; 60(10):1314-1323. PubMed ID: 32459872
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of in vivo anti-hypothermic effect of all stereoisomers of the thyrotropin-releasing hormone mimetic: Rovatirelin Hydrate.
Kobayashi N; Sato N; Sugita K; Takahashi K; Sugawara T; Tada Y; Yoshikawa T
J Pept Sci; 2019 Dec; 25(12):e3228. PubMed ID: 31713944
[TBL] [Abstract][Full Text] [Related]
13. Chronic fluoxetine reverses the effects of chronic corticosterone treatment on α
Horrillo I; Ortega JE; Diez-Alarcia R; Urigüen L; Meana JJ
Neuropharmacology; 2019 Nov; 158():107731. PubMed ID: 31376424
[TBL] [Abstract][Full Text] [Related]
14. Effects of taltirelin hydrate (TA-0910), a novel thyrotropin-releasing hormone analog, on in vivo dopamine release and turnover in rat brain.
Fukuchi I; Asahi T; Kawashima K; Kawashima Y; Yamamura M; Matsuoka Y; Kinoshita K
Arzneimittelforschung; 1998 Apr; 48(4):353-9. PubMed ID: 9608876
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of noradrenaline release from rat frontal cortex by thyrotropin releasing hormone and its analog, (3R,6R)-6-methyl-5-oxo-3-thiomorpholinylcarbonyl-L-histidyl-L-prolinami de, as studied by intracerebral microdialysis.
Itoh Y; Ogasawara T; Yamazaki A; Ukai Y; Miura A; Kimura K
J Pharmacol Exp Ther; 1994 Jan; 268(1):255-61. PubMed ID: 8301565
[TBL] [Abstract][Full Text] [Related]
16. Noradrenergic lesion of the locus coeruleus increases the firing activity of the medial prefrontal cortex pyramidal neurons and the role of alpha2-adrenoceptors in normal and medial forebrain bundle lesioned rats.
Wang Y; Zhang QJ; Liu J; Ali U; Gui ZH; Hui YP; Wang T; Chen L; Li Q
Brain Res; 2010 Apr; 1324():64-74. PubMed ID: 20153300
[TBL] [Abstract][Full Text] [Related]
17. Reversal of hemorrhagic shock in rats using the metabolically stable thyrotropin-releasing hormone analog taltirelin hydrate.
Asai H; Watanabe Y; Yamauchi-Kohno R; Doi O
J Recept Signal Transduct Res; 2011 Dec; 31(6):416-22. PubMed ID: 22044177
[TBL] [Abstract][Full Text] [Related]
18. Regulation of central noradrenergic activity by 5-HT(3) receptors located in the locus coeruleus of the rat.
Ortega JE; Mendiguren A; Pineda J; Meana JJ
Neuropharmacology; 2012 Jun; 62(8):2472-9. PubMed ID: 22401957
[TBL] [Abstract][Full Text] [Related]
19. Brain receptor binding characteristics and pharmacokinetic-pharmacodynamic analysis of thyrotropin-releasing hormone analogues.
Urayama A; Yamada S; Hirano K; Deguchi Y; Kimura R
Life Sci; 2001 Dec; 70(6):647-57. PubMed ID: 11833715
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and Evaluation of in Vivo Anti-hypothermic Effect of the N- and C-Terminus Modified Thyrotropin-Releasing Hormone Mimetic: [(4S,5S)-(5-Methyl-2-oxooxazolidine-4-yl)carbonyl]-[3-(thiazol-4-yl)-L-alanyl]-L-prolinamide.
Kobayashi N; Sato N; Sugita K; Kihara T; Koike K; Sugawara T; Tada Y; Yoshikawa T
Chem Pharm Bull (Tokyo); 2021; 69(4):314-324. PubMed ID: 33790077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
